AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	22	21	15	44	73	4
Market Cap Growth	10.52%	43.27%	-65.93%	-39.56%	1520.00%	-48.46%
Enterprise Value	14	9	-18	-4	36	2
PE Ratio	-	-0.74	-0.77	-2.30	-5.06	-0.48
PS Ratio	109.63	106.36	106.36	326.08	446.80	32.11
PB Ratio	4.38	2.10	0.39	0.77	1.19	0.33
P/FCF Ratio	-1.03	-1.01	-1.22	-3.20	-7.01	-0.49
P/OCF Ratio	-1.03	-1.01	-0.93	-3.15	-7.02	-0.50
EV/Sales Ratio	70.29	45.22	-130.19	-30.36	221.54	14.98
EV/EBITDA Ratio	-0.50	-0.32	0.92	0.22	-2.78	-0.26
EV/EBIT Ratio	-0.50	-0.32	0.94	0.22	-2.63	-0.23
EV/FCF Ratio	-0.69	-0.43	1.49	0.30	-3.48	-0.23
Debt / Equity Ratio	0.69	0.07	0.02	0.00	0.04	0.47
Debt / EBITDA Ratio	-0.11	-0.03	-0.04	-0.01	-0.18	-0.78
Debt / FCF Ratio	-0.15	-0.03	-0.07	-0.01	-0.22	-0.70
Quick Ratio	1.11	1.51	25.12	71.72	35.42	7.83
Current Ratio	1.15	1.68	26.69	74.61	36.58	9.27
Asset Turnover	0.01	0.01	0.00	0.00	0.00	0.01
Interest Coverage	-431.19	-	-	-284.48	-20.43	-21.02
Return on Equity (ROE)	-183.60%	-118.30%	-42.40%	-30.00%	-28.20%	-99.60%
Return on Assets (ROA)	-128.30%	-97.90%	-40.60%	-29.20%	-26.00%	-51.50%
Return on Capital (ROIC)	-407.47%	-291.25%	-50.68%	-32.65%	-23.83%	-62.77%
Earnings Yield	-147.08%	-134.80%	-129.66%	-43.45%	-19.77%	-209.18%
FCF Yield	-106.03%	-98.76%	-81.98%	-31.26%	-14.27%	-203.20%
Buyback Yield / Dilution	-2.19%	-1.12%	-1.49%	-48.67%	-774.15%	-262.71%
Total Shareholder Return	-2.19%	-1.12%	-1.49%	-48.67%	-774.15%	-262.71%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).